Skip to content
10-K

Annual Report

TFF PHARMACEUTICALS, INC.

0001213900-24-027185

← back to feed
Filed
Mar 28, 2024 12:00 AM ET
Period of report
—
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 22, 2024 2.52M sh
Shares Diluted FY 2023 · Dec 31, 2023 1.79M sh
Shares Diluted restated FY 2023 · Dec 31, 2022 1.2M sh
Capex FY 2023 · Dec 31, 2023 $94.75K
Capex FY 2023 · Dec 31, 2022 $1.55M
Operating Cash Flow FY 2023 · Dec 31, 2023 −$16.04M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$27.34M
Cash And Equivalents FY 2023 · Dec 31, 2023 $5.48M
Cash And Equivalents FY 2023 · Dec 31, 2022 $16.61M
Stockholders Equity FY 2023 · Dec 31, 2023 $9.57M
Stockholders Equity FY 2023 · Dec 31, 2022 $22.88M
Stockholders Equity FY 2023 · Dec 31, 2021 $38.74M
Current Liabilities FY 2023 · Dec 31, 2023 $2.43M
Current Liabilities FY 2023 · Dec 31, 2022 $1.13M
Total Liabilities FY 2023 · Dec 31, 2023 $2.46M
Total Liabilities FY 2023 · Dec 31, 2022 $1.24M
Current Assets FY 2023 · Dec 31, 2023 $7.59M
Current Assets FY 2023 · Dec 31, 2022 $19.03M
Total Assets FY 2023 · Dec 31, 2023 $12.03M
Total Assets FY 2023 · Dec 31, 2022 $24.12M
Eps Diluted FY 2023 · Dec 31, 2023 −$11.85
Eps Diluted restated FY 2023 · Dec 31, 2022 −$26.49
Eps Basic FY 2023 · Dec 31, 2023 −$11.85
Eps Basic restated FY 2023 · Dec 31, 2022 −$26.49
Sga Expense FY 2023 · Dec 31, 2023 $10.57M
Sga Expense FY 2023 · Dec 31, 2022 $13.8M
Rd Expense FY 2023 · Dec 31, 2023 $12.06M
Rd Expense FY 2023 · Dec 31, 2022 $18.5M
Net Income FY 2023 · Dec 31, 2023 −$21.24M
Net Income FY 2023 · Dec 31, 2022 −$31.77M
Operating Income FY 2023 · Dec 31, 2023 −$21.89M
Operating Income FY 2023 · Dec 31, 2022 −$31.8M
Revenue FY 2023 · Dec 31, 2023 $733.87K
Revenue FY 2023 · Dec 31, 2022 $495.81K